Genmark Diagnostics (GNMK)
Genmark Diagnostics
NASDAQ:GNMK (4/21/2021, 7:00:01 PM)
After market: 24.1 +0.06 (+0.25%)24.04
0 (0%)
Company Profile
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Company Info
Genmark Diagnostics
5964 LA PLACE COURT
CARLSBAD CA 92008
P: 760-448-4300
CEO: Scott Mendel
GNMK News
3 years ago - WeissLaw LLPSHAREHOLDER ALERT: WeissLaw LLP Reminds STAY, GNMK, LDKB, and PBCT Shareholders About Its Ongoing Investigations
3 years ago - Capital Market LaboratoriesPre-earnings Bullish Momentum Pattern and Trigger in GenMark Diagnostics IncThe Techncial Trigger Driven Stock Trade in GenMark Diagnostics Inc (NASDAQ:GNMK) .
3 years ago - Halper Sadeh LLPINVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm3 years ago - WeissLaw LLPSHAREHOLDER ALERT: WeissLaw LLP Reminds GNMK, LDKB, PBCT, and CTB Shareholders About Its Ongoing Investigations
3 years ago - Halper Sadeh LLP INVESTIGATION ALERT: Halper Sadeh LLP Investigates CLGX, KSHB, AEGN, GNMK; Shareholders Are Encouraged to Contact the FirmNEW YORK, NY / ACCESSWIRE / April 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: CoreLogic, Inc. (NYSE: CLGX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to funds managed by Stone Point Capital and Insight Partners for $80.00 per share in cash. If you are a CoreLogic shareholder, click here to
3 years ago - Halper Sadeh LLPINVESTIGATION ALERT: Halper Sadeh LLP Investigates MLND, KSHB, GNMK, ALXN; Shareholders are Encouraged to Contact the FirmGNMK Twits
Here you can normally see the latest stock twits on GNMK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
